[1]
Ahmed, H., Gomaa, S., Alazzeh, M., Darwish, M., Mansour, M.K. and Lauchner, J. 2026. Sodium-Glucose Cotransporter-2 Inhibitors Are Associated with Improved Survival in Patients with Cirrhosis. Journal of Gastrointestinal and Liver Diseases. 35, 2 (Jun. 2026), 222–228. DOI:https://doi.org/10.15403/jgld-6794.